| Literature DB >> 25453971 |
Lin-Chen Ho1, Chao-Hsiung Hsu2, Chung-Mao Ou1, Chia-Wei Wang1, Tsang-Pai Liu3, Lian-Pin Hwang1, Yung-Ya Lin4, Huan-Tsung Chang5.
Abstract
Developing novel multifunctional nanoparticles (NPs) with robust preparation, low cost, high stability, and flexible functionalizability is highly desirable. This study provides an innovative platform, termed unibody core-shell (UCS), for this purpose. UCS is comprised of two covalent-bonded polymers differed only by the functional groups at the core and the shell. By conjugating Gd(3+) at the stable core and encapsulating doxorubicin (Dox) at the shell in a pH-sensitive manner, we developed a theranostic NPs (UCS-Gd-Dox) that achieved a selective drug release (75% difference between pH 7.4 and 5.5) and MR imaging (r1 = 0.9 and 14.5 mm(-1) s(-1) at pH 7.4 and 5.5, respectively). The anti-cancer effect of UCS-Gd-Dox is significantly better than free Dox in tumor-bearing mouse models, presumably due to enhanced permeability and retention effect and pH-triggered release. To the best of our knowledge, this is the simplest approach to obtain the theranostic NPs with Gd-conjugation and Dox doping.Entities:
Keywords: Core–shell; Drug delivery; Magnetic resonance imaging (MRI); Nanoparticle
Mesh:
Substances:
Year: 2014 PMID: 25453971 DOI: 10.1016/j.biomaterials.2014.10.006
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479